Celldex Therapeutics, Inc

(NASDAQ:CLDX)

Latest On Celldex Therapeutics, Inc (CLDX):

Date/Time Type Description Signal Details
2023-05-18 18:33 ESTNewsCelldex Therapeutics: Revolutionizing Cancer Care With Innovative ImmunotherapiesN/A
2023-05-04 23:29 ESTNewsCelldex GAAP EPS of -$0.62, revenue of $1MN/A
2023-03-02 14:39 ESTNewsCelldex Therapeutics (CLDX) Presents At AAAAI ConferenceN/A
2023-02-28 18:15 ESTNewsCelldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35MN/A
2023-02-27 12:59 ESTNewsCelldex gains 12% on Phase 1 data for urticaria candidateN/A
2023-02-20 07:02 ESTNewsCelldex: Long List Of Failures, High Valuation, But Good Data RecentlyN/A
2022-12-02 20:42 ESTNewsCelldex: Shares Continue To Rally On Barzolvolimab Hope (Technical Analysis)N/A
2022-11-09 22:05 ESTNewsCelldex GAAP EPS of -$0.57 beats by $0.01, revenue of $0.41M beats by $0.05MN/A
2022-08-09 00:09 ESTNewsCelldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24MN/A
2022-07-22 13:36 ESTNewsCelldex begins dosing in mid-stage study of barzolvolimab for skin disorderN/A
2022-07-14 20:11 ESTNewsCelldex: Barzolvolimab Plus Bispecific Antibodies AdvancementN/A
2022-07-01 20:44 ESTNewsCelldex posts early-stage data to support dose-dependent effect of urticaria therapyN/A
2022-05-06 00:47 ESTNewsCelldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39MN/A
2022-03-01 04:31 ESTNewsCelldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84MN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-28 08:33 ESTNewsCelldex Q4 2021 Earnings PreviewN/A
2022-02-17 13:49 ESTNewsCelldex Therapeutics (CLDX) Investor Presentation - SlideshowN/A
2022-02-01 06:48 ESTNewsCelldex: Pipeline Of Drug Candidates Is Worth A LookN/A
2021-11-12 18:41 ESTNewsCelldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody programN/A
2021-11-10 04:54 ESTNewsCelldex EPS misses by $0.09, misses on revenueN/A
2021-09-29 12:19 ESTNewsCelldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patientsN/A
2021-09-24 01:18 ESTNewsCelldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-MakersN/A
2021-08-06 00:09 ESTNewsCelldex EPS beats by $0.06, beats on revenueN/A
2021-07-22 20:52 ESTNewsCelldex rises with bullish call from Guggenheim; potential of lead asset citedN/A
2021-07-21 00:15 ESTNewsCelldex: Powerful Medicines To Yield Further UpsidesN/A
2021-07-21 00:14 ESTNewsCelldex gains over a third on early-stage data for CDX-0159 in skin conditionN/A
2021-07-21 00:13 ESTNewsAnimal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst actionN/A
2021-07-21 00:13 ESTNewsTempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losersN/A
2021-07-21 00:12 ESTNewsCelldex Therapeutics proposes $175M capital raiseN/A
2021-07-21 00:12 ESTNewsCelldex's Latest Data For Chronic Inducible Urticaria Drug Is Only The BeginningN/A
2021-07-21 00:10 ESTNewsCelldex Therapeutics raises $250M via equity offeringN/A
2021-05-07 05:42 ESTNewsCelldex EPS misses by $0.08, misses on revenueN/A
2021-03-30 03:43 ESTNewsCelldex EPS misses by $0.18, beats on revenueN/A
2021-03-29 08:13 ESTNewsCelldex reports 80% complete response rate in CDX-0159 study in skin allergyN/A
2021-03-02 07:24 ESTAnalyst RatingThe Analyst Target Price has increased from $30.67 to $34.33.Buy
2021-02-24 03:23 ESTAnalyst RatingThe Analyst Target Price has increased from $26.33 to $30.67.Buy
2021-02-22 18:38 ESTNewsCelldex to expand development of CDX-0159 into prurigo nodularisN/A
2021-01-17 17:51 ESTNewsCelldex: New Monoclonal Therapeutic Line, 1Q21's CDX-0159's Initial Trial Data, And MoreN/A
2020-12-13 03:34 ESTFinancialsCompany financials have been released.Neutral
2020-12-09 15:50 ESTNewsDosing underway in Celldex's CDX-0159 study in skin allergyN/A
2020-11-19 19:29 ESTAnalyst RatingThe Analyst Target Price has increased from $23.5 to $26.33.Buy
2020-11-10 03:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:34 ESTAnalyst RatingThe Analyst Target Price has increased from $21.5 to $23.5.Buy
2020-11-07 15:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 19:23 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 04:46 ESTNewsCelldex EPS in-line, beats on revenueN/A
2020-11-01 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $17 to $21.5.Buy
2020-10-14 09:13 ESTNewsDosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder studyN/A

About Celldex Therapeutics, Inc (CLDX):

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

CLDX Quotes by TradingView

See Advanced Chart

General

  • Name Celldex Therapeutics, Inc
  • Symbol CLDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 127
  • Last Split Factor1:15
  • Last Split Date2019-02-11
  • Fiscal Year EndDecember
  • IPO Date2008-03-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.celldex.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 133.88
  • Price/Book (Most Recent Quarter) 4.37
  • Enterprise Value Revenue 186.73
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -1150%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 4.52 million
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.19
  • Gross Profit -39099000
  • Quarterly Earnings Growth 22.3%
View More

Highlights

  • Market Capitalization 988.78 million
  • EBITDA -51311000
  • PE Ratio -18.24
  • Analyst Target Price $34.33
  • Book Value Per Share $5.81
View More

Share Statistics

  • Shares Outstanding 39.57 million
  • Shares Float 28.85 million
  • % Held by Insiders 16%
  • % Held by Institutions 82.07%
  • Shares Short 2.87 million
  • Shares Short Prior Month 3.44 million
  • Short Ratio 4.18
  • Short % of Float 7%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.73
  • 52 Week High $30.17
  • 52 Week Low $1.51
  • 50 Day Moving Average 25.2
  • 200 Day Moving Average 18.9
View More

Dividends

  • Dividend Date 2019-02-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Celldex Therapeutics, Inc (CLDX) Dividend Calendar:

CLDX's last dividend payment was made to shareholders on February 11, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Celldex Therapeutics, Inc (CLDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$668000-$0.36-$0.360%
2020-06-302020-08-06$N/A-$0.50-$0.5813.79%
2020-03-312020-05-06$2.73 million-$0.73-$0.70-4.29%
2019-12-312020-03-26$887000-$0.64-$0.9331.18%
2019-09-302019-11-12$546000-$0.75-$0.8410.71%
2019-06-302019-08-07$715000-$0.84-$1.1728.21%
2019-03-312019-05-07$1.43 million-$1.40-$1.14-22.81%
2018-12-312019-03-07$1.76 million-$0.81-$1.2032.5%
2018-09-302018-11-07$941000-$0.60-$2.2573.33%
2018-06-302018-08-08$2.76 million-$1.65-$2.5535.29%
2018-03-312018-05-10$4.07 million-$12.60-$3.03-315.84%
2017-12-312018-03-07$3.46 million-$0.45-$3.7387.92%
2017-09-302017-11-07$3.92 million-$3.00-$3.9824.53%
2017-06-302017-08-08$3.83 million-$3.45-$4.0915.71%
2017-03-312017-05-09$1.53 million-$4.20-$4.281.75%
2016-12-312017-03-14$1.87 million-$4.50-$5.0510.89%
2016-09-302016-11-07$2.22 million-$4.35-$4.9712.42%
2016-06-302016-08-08$1.39 million-$4.80-$5.054.95%
2016-03-312016-05-05$1.3 million-$5.25-$5.24-0.29%
2015-12-312016-02-23$1.79 million-$4.95-$5.204.81%
2015-09-302015-11-05$1.03 million-$0.32-$0.358.57%
2015-06-302015-08-10$2.18 million-$0.33-$0.342.94%
2015-03-312015-04-29$486000-$0.33-$0.368.33%
2014-12-312015-02-24$1.48 million-$0.36-$0.35-2.86%
2014-09-302014-11-05$1.1 million-$0.31-$0.336.06%
2014-06-302014-08-06$592000-$4.80-$4.840.83%
2014-03-312014-05-01$416000-$4.95-$3.94-25.63%
2013-12-312014-03-03$620000-$4.05-$4.183.11%
2013-09-302013-11-08$980000-$4.35-$3.66-18.85%
2013-06-302013-08-06$97000-$3.60-$3.34-7.78%
2013-03-312013-05-02$2.41 million-$3.45-$3.30-4.55%
2012-12-312013-03-07$3.65 million-$4.05-$3.75-8%
2012-09-302012-11-01$3.11 million-$3.75-$3.62-3.59%
2012-06-302012-08-10$2.01 million-$3.45-$3.798.97%
2012-03-312012-05-03$2.43 million-$4.05-$3.57-13.45%
2011-12-312012-03-07$2.43 million-$4.35-$4.17-4.32%
2011-09-302011-11-02$2.36 million-$4.05-$3.84-5.47%
2011-06-302011-08-03$1.95 million-$4.05-$4.295.59%
2011-03-312011-05-04$2.52 million-$4.65-$4.54-2.42%
2010-12-312011-03-03$2.13 million-$3.60$3.15-214.29%
2010-09-302010-11-02$2.41 million-$4.35-$4.8710.68%
2010-06-302010-08-04$2.95 million-$4.50-$3.95-13.92%
2010-03-312010-05-04$3.71 million-$3.15-$3.9520.25%
2009-12-312010-03-04$4.73 million-$6.45-$4.30-50%
2009-09-302009-11-04$4.03 million-$6.75-$8.3218.87%
2009-06-302009-08-05$2.69 million-$8.25-$7.10-16.2%
2009-03-312009-05-05$3.73 million-$7.35-$6.90-6.52%
2008-12-312009-02-27$2.99 million-$7.05-$8.1012.96%
2008-09-302008-11-05$2.36 million-$7.50-$7.20-4.17%
2008-06-302008-08-06$1.96 million-$10.05-$8.40-19.64%
2008-03-312008-05-19$147000-$32.85-$9.97-229.49%
2007-12-312008-02-27$384000-$26.19
2007-09-302007-10-31$269000-$12.60-$12.600%
2007-06-302007-08-02$609000-$12.60-$18.0030%
2007-03-312007-05-03$144000-$87.35
2006-12-312007-03-07$255000-$14.40-$14.400%
2006-09-302006-11-01$199000-$14.40-$12.60-14.29%
2006-06-302006-08-02$317000-$14.40-$12.60-14.29%
2006-03-312006-05-09$128000-$7.20-$5.40-33.33%
2005-12-312006-03-08$36000-$9.00-$10.8016.67%
2005-09-302005-10-27$23000-$10.80-$12.6014.29%
2005-06-302005-08-03$12000-$10.80-$6.30-71.43%
2005-03-312005-05-05$N/A-$12.60-$11.70-7.69%
2004-12-312005-03-02-$9.00-$10.8016.67%
2004-09-302004-10-20-$8.98
2004-06-302004-07-22-$9.00-$9.000%
2004-03-312004-04-21-$5.40-$9.0040%
2003-12-312004-02-24-$9.00-$9.000%
2003-09-302003-10-22-$5.40-$10.8050%
2003-06-302003-07-23-$9.48
2003-03-312003-04-30-$10.01
2002-12-312003-02-26-$10.80-$12.6014.29%
2002-09-302002-10-23-$1.80-$16.2088.89%
2002-06-302002-07-24-$16.20-$17.105.26%
2002-03-312002-04-24-$14.40-$18.0020%
2001-12-312002-02-26-$19.80-$20.402.94%
2001-09-302001-10-25-$19.80-$23.4015.38%
2001-06-302001-08-02-$18.00-$22.8021.05%
2001-03-312001-04-25-$12.60-$16.2022.22%
2000-12-312001-03-01-$14.40-$13.50-6.67%
2000-09-302000-10-25-$12.60-$12.600%
2000-06-302000-06-30-$9.79
2000-03-312000-04-27-$7.20-$10.8033.33%
1996-12-311997-02-19-$16.20-$18.0010%
1996-09-301996-11-06-$18.00-$18.000%
1996-06-301996-07-23-$39.60-$18.00-120%
1995-12-311996-02-27-$28.80-$25.20-14.29%
1995-09-301995-11-10-$32.40-$27.00-20%
1995-06-301995-08-11-$27.00-$25.20-7.14%
1995-03-311995-05-12-$25.20-$23.40-7.69%
1994-12-311995-02-15-$19.80-$35.1043.59%
1994-09-301994-11-10-$23.40-$24.303.7%
1994-06-301994-08-02-$23.40-$25.207.14%
1994-03-311994-05-02-$19.80-$25.2021.43%
1993-09-301993-10-29-$27.00-$21.60-25%
1993-03-311993-05-12-$23.40-$18.00-30%

Celldex Therapeutics, Inc (CLDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Celldex Therapeutics, Inc (CLDX) Chart:

Celldex Therapeutics, Inc (CLDX) News:

Below you will find a list of latest news for Celldex Therapeutics, Inc (CLDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Celldex Therapeutics, Inc (CLDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-16100CALL0 0186.12TRUE00
2025-05-16110CALL0 0172.64TRUE00
2025-05-1612.50CALL0 0234.69TRUE00
2025-05-16140CALL0 096.29TRUE00
2025-05-16152.58CALL0 1090.27TRUE00
2025-05-16162.73CALL0 1581.18TRUE00
2025-05-1617.58CALL0 192.79TRUE00
2025-05-16191.47CALL0 42388.5TRUE00
2025-05-16200.55CALL1 4154.9FALSE0.550
2025-05-16210.65CALL0 31958.36FALSE00
2025-05-1622.51.09CALL0 2567.5FALSE00
2025-05-16240.75CALL0 5376.9FALSE00
2025-05-16250.37CALL0 4586.75FALSE00
2025-05-16260.65CALL0 193.5FALSE00
2025-05-16270.5CALL0 1101.91FALSE00
2025-05-16283.54CALL0 178247.59FALSE00
2025-05-16290.3CALL0 11117.26FALSE00
2025-05-16300.1CALL0 116124.31FALSE00
2025-05-16310CALL0 0128.07FALSE00
2025-05-16320CALL0 0134.38FALSE00
2025-05-16330CALL0 0140.41FALSE00
2025-05-16340CALL0 0146.19FALSE00
2025-05-16350.2CALL0 339151.73FALSE00
2025-05-16360CALL0 0157.05FALSE00
2025-05-16370CALL0 0174.73FALSE00
2025-05-16380CALL0 0167.11FALSE00
2025-05-16390CALL0 0187.75FALSE00
2025-05-16400.1CALL0 147176.48FALSE00
2025-05-16450.02CALL10 37135.51FALSE0.020
2025-05-16500.5CALL0 46215.54FALSE00
2025-05-16551.25CALL0 2231.51FALSE00
2025-05-16600CALL0 0245.77FALSE00
2025-05-16650CALL0 0278.32FALSE00
2025-05-16100PUT0 0197.8FALSE00
2025-05-16110PUT0 0174.15FALSE00
2025-05-1612.50PUT0 0142.23FALSE00
2025-05-16140.35PUT0 1128.39FALSE00
2025-05-16151.03PUT0 295.53FALSE00
2025-05-16160.8PUT0 50080.8FALSE00
2025-05-1617.51.35PUT0 862.64FALSE00
2025-05-16192.43PUT0 156.1FALSE00
2025-05-16201.5PUT0 1537.27TRUE00
2025-05-16210PUT0 081.85TRUE00
2025-05-1622.53.7PUT0 5992.84TRUE00
2025-05-16240PUT0 097.67TRUE00
2025-05-16254.6PUT0 5689.26TRUE00
2025-05-16260PUT0 093.88TRUE00
2025-05-16274.87PUT0 178120.48TRUE00
2025-05-16280PUT0 098.49TRUE00
2025-05-16290PUT0 0105.65TRUE00
2025-05-16309.3PUT0 473130.7TRUE00
2025-05-16310PUT0 0110.54TRUE00
2025-05-16320PUT0 0187.99TRUE00
2025-05-16330PUT0 0138.44TRUE00
2025-05-16340PUT0 0198.16TRUE00
2025-05-16350PUT0 0178.67TRUE00
2025-05-16360PUT0 0174.2TRUE00
2025-05-16370PUT0 0179.75TRUE00
2025-05-16380PUT0 0185.1TRUE00
2025-05-16390PUT0 0206.06TRUE00
2025-05-164013.3PUT0 0195.27TRUE00
2025-05-16450PUT0 0218.06TRUE00
2025-05-16500PUT0 0224.03TRUE00
2025-05-16550PUT0 0248.58TRUE00
2025-05-16600PUT0 0271.14TRUE00
2025-05-16650PUT0 0285.44TRUE00
2025-06-20100CALL0 0171.13TRUE00
2025-06-20110CALL0 087.76TRUE00
2025-06-20120CALL0 082.74TRUE00
2025-06-20130CALL0 063.85TRUE00
2025-06-20140CALL0 0147.8TRUE00
2025-06-20150CALL0 071.11TRUE00
2025-06-20160CALL0 082.97TRUE00
2025-06-20170CALL0 062.52TRUE00
2025-06-20180CALL0 052.74TRUE00
2025-06-20190CALL0 075.46TRUE00
2025-06-20200CALL0 073.1FALSE00
2025-06-20210CALL0 048.92FALSE00
2025-06-20220CALL0 051.3FALSE00
2025-06-20230CALL0 060.91FALSE00
2025-06-20240CALL0 056.53FALSE00
2025-06-20250.45CALL2 060.86FALSE0.450
2025-06-20260CALL0 066.9FALSE00
2025-06-20300CALL0 083.14FALSE00
2025-06-20350CALL0 095.77FALSE00
2025-06-20100PUT0 0126.49FALSE00
2025-06-20110PUT0 0111.51FALSE00
2025-06-20120PUT0 097.77FALSE00
2025-06-20130PUT0 087.17FALSE00
2025-06-20140PUT0 082.13FALSE00
2025-06-20150PUT0 078.54FALSE00
2025-06-20160PUT0 067.11FALSE00
2025-06-20170PUT0 069.36FALSE00
2025-06-20180PUT0 062.75FALSE00
2025-06-20190PUT0 083.01FALSE00
2025-06-20200PUT0 059.39TRUE00
2025-06-20210PUT0 070.45TRUE00
2025-06-20220PUT0 044.97TRUE00
2025-06-20230PUT0 063.04TRUE00
2025-06-20240PUT0 072.97TRUE00
2025-06-20250PUT0 067.98TRUE00
2025-06-20260PUT0 098.79TRUE00
2025-06-20300PUT0 0110.52TRUE00
2025-06-20350PUT0 094.49TRUE00
2025-08-1550CALL0 088.04TRUE00
2025-08-1580CALL0 0102.6TRUE00
2025-08-15107.31CALL0 10183.81TRUE00
2025-08-15110CALL0 083.56TRUE00
2025-08-15120CALL0 081.65TRUE00
2025-08-15130CALL0 082.76TRUE00
2025-08-15140CALL0 065.4TRUE00
2025-08-15154.22CALL0 2577.25TRUE00
2025-08-15160CALL0 051.56TRUE00
2025-08-1517.510.2CALL0 172.74TRUE00
2025-08-15192.55CALL0 3067.75TRUE00
2025-08-15202.2CALL0 4173.89FALSE00
2025-08-15211.7CALL0 10166.58FALSE00
2025-08-1522.51.55CALL0 15366.42FALSE00
2025-08-15240.95CALL0 1257.76FALSE00
2025-08-15251.2CALL0 1057.21FALSE00
2025-08-15261.1CALL0 259.22FALSE00
2025-08-15273.6CALL0 460.65FALSE00
2025-08-15281.9CALL0 1062.33FALSE00
2025-08-15292.5CALL0 1383.82FALSE00
2025-08-15301.3CALL0 2064.34FALSE00
2025-08-15311.05CALL0 1166.63FALSE00
2025-08-15320.74CALL0 167.68FALSE00
2025-08-15332.1CALL0 069.5FALSE00
2025-08-15342CALL0 269.98FALSE00
2025-08-15351.8CALL0 770.11FALSE00
2025-08-15360CALL0 072.54FALSE00
2025-08-15372.3CALL0 177.42FALSE00
2025-08-15380CALL0 086.59FALSE00
2025-08-15390.35CALL0 377.93FALSE00
2025-08-15400.35CALL0 3101.05FALSE00
2025-08-1550PUT0 0165.76FALSE00
2025-08-1580PUT0 0112.83FALSE00
2025-08-15100PUT0 090.52FALSE00
2025-08-15110PUT0 083.54FALSE00
2025-08-15120PUT0 076.56FALSE00
2025-08-15130PUT0 072.15FALSE00
2025-08-15141.05PUT0 568.11FALSE00
2025-08-15152.48PUT0 2463.26FALSE00
2025-08-15161.7PUT0 658.57FALSE00
2025-08-1517.52.52PUT0 2863.52FALSE00
2025-08-15192.1PUT0 159.07FALSE00
2025-08-15204.31PUT0 871.47TRUE00
2025-08-15213.9PUT0 475.9TRUE00
2025-08-1522.58.1PUT0 351.2TRUE00
2025-08-15248PUT0 163.14TRUE00
2025-08-152510.7PUT0 38053.94TRUE00
2025-08-15260PUT0 055.74TRUE00
2025-08-15270PUT0 073.52TRUE00
2025-08-15280PUT0 076.6TRUE00
2025-08-15296.6PUT0 194.46TRUE00
2025-08-15307.3PUT0 195.97TRUE00
2025-08-15310PUT0 072.01TRUE00
2025-08-15320PUT0 071.25TRUE00
2025-08-15330PUT0 072.08TRUE00
2025-08-15340PUT0 077.4TRUE00
2025-08-15350PUT0 098.99TRUE00
2025-08-15360PUT0 089.51TRUE00
2025-08-15370PUT0 096.15TRUE00
2025-08-15380PUT0 092.9TRUE00
2025-08-15390PUT0 099.58TRUE00
2025-08-15400PUT0 093.36TRUE00
2025-11-2150CALL0 089.93TRUE00
2025-11-2180CALL0 072.12TRUE00
2025-11-21100CALL0 083.18TRUE00
2025-11-21110CALL0 047.71TRUE00
2025-11-21120CALL0 057.38TRUE00
2025-11-21130CALL0 071.39TRUE00
2025-11-21140CALL0 056.62TRUE00
2025-11-21150CALL0 071.94TRUE00
2025-11-21160CALL0 071.19TRUE00
2025-11-21170CALL0 070.66TRUE00
2025-11-21180CALL0 086.39TRUE00
2025-11-21190CALL0 060.33TRUE00
2025-11-21203.3CALL0 264.64FALSE00
2025-11-21213.1CALL0 372.36FALSE00
2025-11-21223.55CALL0 1267.05FALSE00
2025-11-21232.9CALL0 168.87FALSE00
2025-11-21242.9CALL1 371.06FALSE2.90
2025-11-21252.45CALL0 167.31FALSE00
2025-11-21262.4CALL1 070.84FALSE2.40
2025-11-21272CALL0 270.59FALSE00
2025-11-21280CALL0 081.85FALSE00
2025-11-21300CALL0 079.3FALSE00
2025-11-21352CALL0 462.03FALSE00
2025-11-2150PUT0 0122.16FALSE00
2025-11-2180.4PUT0 183.38FALSE00
2025-11-21100PUT0 072.84FALSE00
2025-11-21110PUT0 069.21FALSE00
2025-11-21121.9PUT0 167FALSE00
2025-11-21132.35PUT0 163.97FALSE00
2025-11-21140PUT0 074.96FALSE00
2025-11-21150PUT0 071.32FALSE00
2025-11-21164.2PUT0 167.84FALSE00
2025-11-21172.6PUT0 171.87FALSE00
2025-11-21183.1PUT0 178.38FALSE00
2025-11-21190PUT0 059.83FALSE00
2025-11-21204.1PUT0 173.99TRUE00
2025-11-21210PUT0 060.84TRUE00
2025-11-21226.4PUT0 161.78TRUE00
2025-11-21237.2PUT0 157.84TRUE00
2025-11-21240PUT0 066.16TRUE00
2025-11-21250PUT0 074.12TRUE00
2025-11-21260PUT0 068.76TRUE00
2025-11-21270PUT0 065.38TRUE00
2025-11-21280PUT0 068.95TRUE00
2025-11-21300PUT0 069.66TRUE00
2025-11-21350PUT0 069.27TRUE00
2025-12-1930CALL0 0138.51TRUE00
2025-12-1950CALL0 080.01TRUE00
2025-12-1980CALL0 091.94TRUE00
2025-12-19100CALL0 079.25TRUE00
2025-12-1912.56.35CALL0 1664.7TRUE00
2025-12-19140CALL0 071.5TRUE00
2025-12-19154.5CALL0 371.34TRUE00
2025-12-19160CALL0 064.3TRUE00
2025-12-1917.54.41CALL0 1968.56TRUE00
2025-12-19190CALL0 076.61TRUE00
2025-12-19204.4CALL0 1768.94FALSE00
2025-12-19210CALL0 078.97FALSE00
2025-12-1922.52.64CALL0 2167.53FALSE00
2025-12-19240CALL0 067.63FALSE00
2025-12-19252.05CALL0 3468.93FALSE00
2025-12-19260CALL0 068.27FALSE00
2025-12-19271.65CALL0 766.45FALSE00
2025-12-19280CALL0 063.36FALSE00
2025-12-19290CALL0 066.75FALSE00
2025-12-19302CALL0 31966.03FALSE00
2025-12-19321.7CALL0 20056.49FALSE00
2025-12-19351.5CALL0 2565.51FALSE00
2025-12-19370CALL0 068.21FALSE00
2025-12-19401.91CALL0 1287.36FALSE00
2025-12-19452.02CALL0 31104.72FALSE00
2025-12-19500.35CALL0 4268.49FALSE00
2025-12-19550.2CALL0 770.21FALSE00
2025-12-19600.4CALL0 1492.54FALSE00
2025-12-19650.8CALL0 28126.09FALSE00
2025-12-1930PUT0 0218.33FALSE00
2025-12-1950PUT0 0120.17FALSE00
2025-12-1980.65PUT0 194.42FALSE00
2025-12-19101PUT0 174.7FALSE00
2025-12-1912.51.55PUT0 1465.05FALSE00
2025-12-19140PUT0 058.99FALSE00
2025-12-19152PUT0 1069FALSE00
2025-12-19160PUT0 057.54FALSE00
2025-12-1917.52.5PUT0 2372.55FALSE00
2025-12-19190PUT0 070.59FALSE00
2025-12-19206.4PUT0 270.85TRUE00
2025-12-19210PUT0 070.55TRUE00
2025-12-1922.58.2PUT0 169.19TRUE00
2025-12-19240PUT0 069.21TRUE00
2025-12-19258.8PUT0 572.73TRUE00
2025-12-19260PUT0 056TRUE00
2025-12-19270PUT0 060.46TRUE00
2025-12-19280PUT0 078.27TRUE00
2025-12-19290PUT0 067.02TRUE00
2025-12-193016.1PUT0 93766.31TRUE00
2025-12-19320PUT0 059.19TRUE00
2025-12-19350PUT0 060.74TRUE00
2025-12-19370PUT0 064.85TRUE00
2025-12-194013.2PUT0 570.55TRUE00
2025-12-19450PUT0 075.42TRUE00
2025-12-19500PUT0 082.75TRUE00
2025-12-19550PUT0 096.42TRUE00
2025-12-19600PUT0 095.28TRUE00
2025-12-19650PUT0 098.52TRUE00

Latest CLDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$20.54
Jun 13, 2022 7:59 PM EST61$20.52
Jun 13, 2022 7:59 PM EST28$20.52
Jun 13, 2022 7:59 PM EST1$20.51
Jun 13, 2022 7:59 PM EST190$20.54

Celldex Therapeutics, Inc (CLDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000003877718000054/0000038777-18-000054-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000021545718005851/0000215457-18-005851-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001108/0000315066-18-001108-index.htm
2018-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001910/0000315066-18-001910-index.htm
2020-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000090266420002780/0000902664-20-002780-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247118003136/0000932471-18-003136-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247119004430/0000932471-19-004430-index.htm
2020-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093583620000571/0000935836-20-000571-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000103738920000083/0001037389-20-000083-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746918001363/0001047469-18-001363-index.htm
2018-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918002964/0001047469-18-002964-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918003326/0001047469-18-003326-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746919000992/0001047469-19-000992-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746919002607/0001047469-19-002607-index.htm
2019-12-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/0001047469-19-006714-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746920001809/0001047469-20-001809-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746920002644/0001047469-20-002644-index.htm
2020-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003564/0001047469-20-003564-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003601/0001047469-20-003601-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003602/0001047469-20-003602-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003646/0001047469-20-003646-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918026170/0001104659-18-026170-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918031972/0001104659-18-031972-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918037447/0001104659-18-037447-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918040165/0001104659-18-040165-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918050496/0001104659-18-050496-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918066648/0001104659-18-066648-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918070024/0001104659-18-070024-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918072097/0001104659-18-072097-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919006667/0001104659-19-006667-index.htm
2019-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/744218/000110465919027504/0001104659-19-027504-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919027513/0001104659-19-027513-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919036671/0001104659-19-036671-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919036997/0001104659-19-036997-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919037010/0001104659-19-037010-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919037195/0001104659-19-037195-index.htm
2019-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000110465919039565/0001104659-19-039565-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919044531/0001104659-19-044531-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919062181/0001104659-19-062181-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000110465920039253/0001104659-20-039253-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920057436/0001104659-20-057436-index.htm
2020-06-12S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000110465920072503/0001104659-20-072503-index.htm
2020-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/744218/000110465920072779/0001104659-20-072779-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920072934/0001104659-20-072934-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073386/0001104659-20-073386-index.htm
2020-06-15S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/744218/000110465920073505/0001104659-20-073505-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073843/0001104659-20-073843-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920074646/0001104659-20-074646-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465920077437/0001104659-20-077437-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920091459/0001104659-20-091459-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920096505/0001104659-20-096505-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920121786/0001104659-20-121786-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/744218/000110465920122483/0001104659-20-122483-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920122521/0001104659-20-122521-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318001754/0001171843-18-001754-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318002723/0001171843-18-002723-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318003787/0001171843-18-003787-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318005867/0001171843-18-005867-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318007706/0001171843-18-007706-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319001578/0001171843-19-001578-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319003062/0001171843-19-003062-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319005251/0001171843-19-005251-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319007429/0001171843-19-007429-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320002037/0001171843-20-002037-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320003372/0001171843-20-003372-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320005651/0001171843-20-005651-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320007664/0001171843-20-007664-index.htm
2018-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018003192/0001179110-18-003192-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018005108/0001179110-18-005108-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018006035/0001179110-18-006035-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018007858/0001179110-18-007858-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008556/0001179110-18-008556-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008557/0001179110-18-008557-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008558/0001179110-18-008558-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008559/0001179110-18-008559-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008560/0001179110-18-008560-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008561/0001179110-18-008561-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008562/0001179110-18-008562-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008563/0001179110-18-008563-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008564/0001179110-18-008564-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008565/0001179110-18-008565-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008566/0001179110-18-008566-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008567/0001179110-18-008567-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008568/0001179110-18-008568-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008569/0001179110-18-008569-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008570/0001179110-18-008570-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018009240/0001179110-18-009240-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010087/0001179110-18-010087-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018011797/0001179110-18-011797-index.htm
2018-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018012450/0001179110-18-012450-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018013378/0001179110-18-013378-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007967/0001179110-19-007967-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007968/0001179110-19-007968-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007969/0001179110-19-007969-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007970/0001179110-19-007970-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007971/0001179110-19-007971-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007972/0001179110-19-007972-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007973/0001179110-19-007973-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007974/0001179110-19-007974-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007975/0001179110-19-007975-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007976/0001179110-19-007976-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007977/0001179110-19-007977-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007978/0001179110-19-007978-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007979/0001179110-19-007979-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019008540/0001179110-19-008540-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007585/0001179110-20-007585-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007586/0001179110-20-007586-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007587/0001179110-20-007587-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007588/0001179110-20-007588-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007589/0001179110-20-007589-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007590/0001179110-20-007590-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007591/0001179110-20-007591-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007592/0001179110-20-007592-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007593/0001179110-20-007593-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007594/0001179110-20-007594-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007595/0001179110-20-007595-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007596/0001179110-20-007596-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007597/0001179110-20-007597-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007598/0001179110-20-007598-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000118248918000319/0001182489-18-000319-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312518041541/0001193125-18-041541-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312519039738/0001193125-19-039738-index.htm
2020-06-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312520171962/0001193125-20-171962-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000149315220011453/0001493152-20-011453-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/744218/999999999520001412/9999999995-20-001412-index.htm
2018-04-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/744218/999999999718005092/9999999997-18-005092-index.htm

Celldex Therapeutics, Inc (CLDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc (CLDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 16%
Institutional Ownership: 8207%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-09Margo Heath-ChiozziSVP of Regulatory AffairsBuy1,000.003.013,005.001,000.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-09Samuel Bates MartinSVP and CFOBuy9,750.003.0529,737.5010,735.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-09JAMES J MARINODirectorBuy8,305.003.0024,915.0012,704.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-10Sarah CavanaughSVP of Corp Affairs & Admin.Buy1,050.004.835,071.501,367.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-09Anthony S MarucciPresident & CEOBuy15,000.003.0645,900.0019,438.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-11Diane C. YoungSVP, Chief Medical OfficerBuy2,115.004.7310,003.952,115.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2018-06-15TIBOR KELERExecutive VP & CSOBuy16,500.000.599,782.8535,368.00https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-08-24JAMES J MARINODirectorBuy40,000.000.4819,200.0065,997.00https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2020-06-09TIBOR KELERExecutive VP & CSOBuy5,000.002.9914,954.007,357.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm